General
Showing 1153–1168 of 1205 results
-
Article: Trastuzumab deruxtecan solidified as the preferred 2nd line treatment for patients with HER2-positive metastatic BC: updated results from DESTINY-Breast03
€3.03 Only for registered clients -
Article: Traveling the prostate cancer timeline in chase of treatment paradigms: Can we cure the incurable?
€3.03 Only for registered clients -
Article: Treat mTNBC with more support. Visit GileadPro.be.
€3.03 Only for registered clients -
Article: Treating upper digestive bleeding may cause multiple infectious complications in a cancer patient
€3.03 Only for registered clients -
Article: Treatment algorithm ER positive HER2 negative Advanced Breast Cancer
€3.03 Only for registered clients -
Article: Treatment of metastatic melanoma: an update on the Belgian situation
€3.03 Only for registered clients -
Article: Treatment of non-small cell lung carcinoma with gefitinib: a case report
€3.03 Only for registered clients -
Article: Treatment of poor-prognosis germ-cell tumours
€3.03 Only for registered clients -
Article: Treatment options in patients with early breast cancer and BRCA-mutations or family history of cancer
€3.03 Only for registered clients -
Article: Treatment sequencing in patients with advanced mutant melanoma
€3.03 Only for registered clients -
Article: Treatment-induced anaemia in solid tumours with emphasis on newer anti-cancer drugs
€3.03 Only for registered clients -
Article: Tribute to Uro-Oncology
€3.03 Only for registered clients -
Article: Triple-negative breast cancer: current treatment and future perspectives
€3.03 Only for registered clients -
Article: Tumoral melanosis associated with ipilimumab plus nivolumab-treated metastatic melanoma: A case report and review of the literature
€3.03 Only for registered clients -
Article: Tumour markers in metastatic colorectal cancer: clinical implications for treatment with targeted therapy
€3.03 Only for registered clients -
Article: Tumour mutational burden: a review
€3.03 Only for registered clients